Skip to main content

Advertisement

Fig. 1 | BMC Cancer

Fig. 1

From: Modeling and simulation of maintenance treatment in first-line non-small cell lung cancer with external validation

Fig. 1

Theoretical tumor size profile over first-line treatment run-in phase and maintenance treatment phase. t1: time of randomization to maintenance treatment; KL: growth rate (assumed to be same during the two treatment phases); TS, KDE and λ: tumor size, drug effect and drug effect decay over time, respectively, for the first-line (TS1, KDE1 and λ1) and maintenance (TS2, KDE2 and λ2) phase; RND: randomization

Back to article page